Jefferies, Deutsche and Cowen assist; deal funds clinical development
By Devika Patel
Knoxville, Tenn., April 11 - Regado Biosciences, Inc. said it priced a $60 million public sale of stock with a $9 million greenshoe. The offering was announced April 3.
The company will sell 10 million common shares at $6.00 per share. The price per share reflects a 16.32% discount to the April 10 closing share price of $7.17.
Jefferies LLC, Deutsche Bank Securities and Cowen and Co., LLC will be the joint bookrunning managers.
Settlement is expected April 16.
Proceeds will be used for clinical development, working capital and other general corporate purposes.
The biopharmaceutical company is based in Basking Ridge, N.J.
| Issuer: | Regado Biosciences, Inc.
|
| Issue: | Common stock
|
| Amount: | $60 million
|
| Greenshoe: | $9 million
|
| Shares: | 10 million
|
| Price: | $6.00
|
| Warrants: | No
|
| Bookrunners: | Jefferies LLC, Deutsche Bank Securities and Cowen and Co., LLC
|
| Announcement date: | April 3
|
| Pricing date: | April 11
|
| Settlement date: | April 16
|
| Stock symbol: | Nasdaq: RGDO
|
| Stock price: | $7.17 at close April 10
|
| Market capitalization: | $152.91 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
